Brief: Ocuphire Appoints Rick Rodgers As Interim Chief Executive Officer
21/04/2023 13:04
April 21 (Reuters) - Ocuphire Pharma Inc OCUP.O :
* OCUPHIRE APPOINTS RICK RODGERS AS INTERIM CHIEF EXECUTIVE
OFFICER
* OCUPHIRE PHARMA INC - RICK RODGERS IS SUCCEEDING MINA
SOOCH
* OCUPHIRE PHARMA INC - HAS RETAINED AN EXECUTIVE SEARCH
FIRM TO
ASSIST IN IDENTIFYING A PERMANENT CEO
Source text for Eikon: ID:nGNX5hTNRJ
Further company coverage: OCUP.O
Recent news on Opus Genetics
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data